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In the brain, insulin plays an important role in cognitive processes. During aging,
these faculties decline, as does insulin signaling. The mechanism behind this last
phenomenon is unclear. In recent studies, we reported that the mild and gradual loss
of cholesterol in the synaptic fraction of hippocampal neurons during aging leads to
a decrease in synaptic plasticity evoked by glutamate receptor activation and also
by receptor tyrosine kinase (RTK) signaling. As insulin and insulin growth factor
activity are dependent on tyrosine kinase receptors, we investigated whether the
constitutive loss of brain cholesterol is also involved in the decay of insulin function
with age. Using long‐term depression (LTD) induced by application of insulin to hip-
pocampal slices as a read‐out, we found that the decline in insulin function during
aging could be monitored as a progressive impairment of insulin‐LTD. The applica-
tion of a cholesterol inclusion complex, which donates cholesterol to the membrane
and increases membrane cholesterol levels, rescued the insulin signaling deficit and
insulin‐LTD. In contrast, extraction of cholesterol from hippocampal neurons of adult
mice produced the opposite effect. Furthermore, in vivo inhibition of Cyp46A1, an
enzyme involved in brain cholesterol loss with age, improved insulin signaling. Fluo-
rescence resonance energy transfer (FRET) experiments pointed to a change in
receptor conformation by reduced membrane cholesterol, favoring ligand‐indepen-
dent autophosphorylation. Together, these results indicate that changes in mem-
brane fluidity of brain cells during aging play a key role in the decay of synaptic
plasticity and cognition that occurs at this late stage of life.
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1 | INTRODUCTION
Brain insulin has been traditionally associated with important roles in
the organism: regulation of appetite, body temperature, response to
hypoglycemia, and others (Kleinridders, Ferris, Cai, & Kahn, 2014). In
addition, recent studies strongly indicate a central role for insulin in
cognitive processes and the underlying synaptic processes (Biessels
& Reagan, 2015; Haj‐ali, Mohaddes, & Babri, 2009; Moosavi,
Naghdy, & Choopani, 2007). Thus, insulin modulates long‐term
potentiation (LTP) in the hippocampal CA1 region (Grillo et al., 2015;
Martin et al., 2012; Nisticó et al., 2012) and can induce on its own,
that is, without the need of further electrical stimuli, hippocampal
long‐term depression (LTD; hereinafter referred to as insulin‐LTD;
Ahmadian et al., 2004; Huang, Lee, & Hsu, 2004; Man et al., 2000).
LTD is increasingly recognized as a second main form of synaptic
plasticity that is important for learning and memory (Collingridge,
Peineau, Howland, & Wang, 2010; Ge et al., 2010; Kemp & Mana-
han-Vaughan, 2007). This also provides, at least in part, the rationale
for the role of brain insulin in the development of neurodegenerative
diseases and the clinical impact of intranasal insulin administration
on mood and memory recall (Benedict et al., 2007; Carro, Trejo,
Gomez‐Isla, LeRoith, & Torres‐Aleman, 2002; Freiherr et al., 2013).
Aging affects insulin and insulin growth factor 1 (IGF‐1) signaling
(Fernandes, Saad, & Velloso, 2001; Frölich et al., 1998). Clinical and
preclinical studies have shown a reduction of insulin and IGF‐1
receptors, their message, and their function in the hippocampus dur-
ing normal and pathological aging (Deak & Sonntag, 2012; Talbot &
Wang, 2014; Zaia & Piantanelli, 2000). Altered brain insulin signaling
in the old often accompanies peripheral insulin resistance due to
metabolic deregulation in type 2 diabetes (T2D; Biessels & Reagan,
2015; Bruehl et al., 2009) or neurodegenerative diseases such as
Alzheimer's disease (AD; Talbot et al., 2012). However, brain insulin
resistance also develops independently of T2D or AD (Steculorum
et al., 2014) and it remains unclear how normal aging can induce
these alterations.
Here, we propose that the brain insulin signaling deficit with age
is the consequence of the changes in the lipid composition of the
neuronal plasma membrane that occurs with natural aging (Martín,
Pfrieger, & Dotti, 2014). We envision that changes in lipid content
will lead to a reorganization of plasma membrane receptors and
receptor‐associated scaffold resulting in signaling alterations of
diverse pathways, including the insulin pathway. A number of obser-
vations support this prediction. First, several cell types of diabetic
individuals present changes in the ratios of cholesterol, sphin-
gomyelin, and saturated fatty acids (reviewed in Pilon, 2016). Sec-
ond, the hippocampi of old rodents and humans present significant
changes in lipid composition, particularly a reduction in cholesterol
(Colin et al., 2016; Haughey, Bandaru, Bae, & Mattson, 2010; Sven-
nerholm, Boström, Jungbjer, & Olsson, 1994). Third, the decrease in
neuronal cholesterol has also been observed in murine models of
T2D (Suzuki et al., 2010; Suzuki, Ferris, Chee, Maratos‐Flier, & Kahn,
2013). In support of a cause–effect relationship, two recent studies
have shown that the mild reduction of cholesterol in the hippocam-
pus is involved in the cognitive deficits of old mice, via inhibiting
AMPA receptor internalization and reducing the transcription of
learning and memory genes in response to a cognitive stimulus (Mar-
tin et al., 2014); Palomer et al., 2016). Moreover, in models of T2D,
the reduction of neuronal cholesterol plays a decisive role in the loss
of cognitive capacity in this situation (Suzuki, Ferris, Chee, Maratos‐
Flier, & Kahn, 2013).
2 | RESULTS
Numerous studies have demonstrated the existence of a deficit in
insulin function in aged brains. However, it is not known how these
defects affect insulin‐dependent synaptic functions. We observed
that insulin‐induced long‐term depression (insulin‐LTD) was impaired
in old mice (20–24 months old) compared to adult mice (7–
12 months old; Figure 1a). To gain insight into how this insulin defi-
cit occurs, we performed an immunoprecipitation‐based analysis of
receptor activity in the hippocampus of adult and old mice in basal
conditions. This experiment revealed that both insulin receptor (IR)
and insulin‐like growth factor 1 receptor (IGF‐1R) are constitutively
expressed at a higher level in old mice compared to young ones
(Figure 1b,c). Among other possible explanations, the deficit in insu-
lin‐LTD (Figure 1a) in conditions of high receptor activity (Figure 1b,
c) may be due to the high PI3K activity. This possibility finds support
in the fact that activation of IR/IGF‐1R would have produced activa-
tion of PI3K, which would phosphorylate PIP2 to PIP3, in turn
F IGURE 1 Insulin signaling is impaired in old mice due to PI3K/Akt hyperactivation. (a) Insulin‐LTD is completely abolished in old mice (20–
24 months old; n = 7) compared to adult mice (7–12 months old; n = 10). The graphic represents insulin‐LTD as fEPSP slope. Gray box
indicates the time of insulin application. Representative analogue traces on the right were collected at the indicated time points. (b) Insulin
receptor (IR) basal activity levels detected by Western blot using Phospho‐Tyrosine 1150/1151 antibody after total protein
immunoprecipitation. (c) Western blots reflect IGF‐1R Phospho‐Tyrosine 1135/1136 basal levels after total protein immunoprecipitation. Old
mice hippocampus shows higher basal activity levels of IR and IGF1‐R compared to adult mice. (d) Akt Phospho‐Serine 473 activating residue
detected by Western blot in adult and old mice hippocampus at basal level. (e) Western blot analysis of GSK3β in hippocampal extracts from
adult and old mice. Consistent with Akt hyperactivation, the old hippocampus presents high GSK3β inhibitory mark (Phospho‐Serine 9). (f, g)
PI3K/Akt inhibition rescues insulin‐LTD in old mice. Graphics showing insulin‐LTD induction in hippocampal slices from old mice incubated
with Wortmannin (f; 0.5 μM; n = 7) and Quercetin (g; 20 μM; n = 8). Black box indicates time of insulin application. Gray box indicates time of
inhibitors application. Representative analogue traces below were collected at the indicated time points. Numbers in bars reflect number of
independent experiments. Data are represented as mean ± SEM. t test for (b, c, d, e), one‐way ANOVA with post hoc Bonferroni's test for (a,
f, g). The asterisks p values (*p < 0.05; **p < 0.01; ns = not significant)
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activating Akt to phosphorylate GSK3β on Serine residue 9 (an
inhibitory effect), resulting in the inhibition of hippocampal LTD
(Peineau et al., 2007). Consistent with this view, we observed higher
levels of active Akt in the hippocampus of old mice compared to
adult mice (Figure 1d), and also higher levels of Serine 9‐phosphory-
lated GSK3β (Figure 1e). Moreover, insulin was able to evoke LTD in
hippocampal slices from old mice that were pre‐incubated with PI3K/
Akt inhibitors, but not in vehicle‐treated control slices (Figure 1f,g).
Reduced insulin function in a cellular background of high levels
of active receptor and post‐receptor (PI3K/Akt) phosphorylation
speaks in favor of the hippocampus of old mice being in a state of
insulin desensitization (Zick, 2001). In agreement, hippocampal activ-
ity levels of the Akt downstream targets mTOR, p70S6K, and the
resulting negative feedback on PI3K‐adaptor protein IRS‐1 (inhibitory
phosphorylation at Serine residues 632 and 307 and 1101; Zick,
2001) are higher in the hippocampus of old vs. adult mice (Support-
ing Information Figures S1A‐C and S7A,B). In addition, IRS‐2, another
IRS family protein that has been previously related to disrupted plas-
ticity in the hippocampus (Costello et al., 2012), shows a trend to be
reduced in old mice compared to adult mice (Supporting Information
Figure S7C). Finally, another result that supports the existence of a
desensitized route during old age is the reduced activation of the
insulin receptor in response to peripheral insulin stimulation (Sup-
porting Information Figure S1D) (Fernandez & Torres‐Alemán, 2012).
In summary, these results reveal that one reason for the decrease in
insulin function in the aged brain is an increase in PI3K/Akt activity,
in part due to the chronic activity of tyrosine kinase receptors, such
as those for insulin and IGF‐1 (also shown below).
Numerous studies have described changes in brain cholesterol
and their correlation with cognitive deficits during aging, and in brain
disorders such as Alzheimer's disease and T2D (Kadish et al., 2009;
Suzuki, Ferris, Chee, Maratos‐Flier, & Kahn, 2013; Suzuki et al.,
2010). In previous works, we showed that in the mouse there is also
a correlation between cognitive deficit and reduction of membrane
cholesterol in the hippocampus (Martín et al., 2014; Palomer et al.,
2016; Trovò, Van Veldhoven, Martín, & Dotti, 2011). These observa-
tions moved us to test whether hippocampal membrane cholesterol
reduction could be involved in the insulin‐desensitized state. To test
this possibility, we reduced cholesterol levels in cultured hippocam-
pal neurons by cholesterol oxidase (Choox) treatment. Choox was
used at a concentration leading to a mild (~20%) reduction of plasma
membrane cholesterol, without affecting cell viability (our previous
works: Brachet et al., 2015; Palomer et al., 2016). Choox‐mediated
cholesterol reduction led to an increase in phosphorylated IR and
IGF‐1R (Supporting Information Figure S2A). Furthermore, choles-
terol reduction also resulted in higher phosphorylation levels of Akt
(Supporting Information Figure S2B), mTOR (Supporting Information
Figure S7D), p70S6K (Supporting Information Figure S2C), and IRS‐1
at Serine 632, 307, and 1,101 (Supporting Information Figures S2D,
E, and S7E). Cholesterol reduction was also sufficient to lead to a
reduction of IRS‐2 levels (Supporting Information Figure S7F). To
assess whether downstream receptor activation by cholesterol
reduction was due to activation of IRs, Choox‐treated neurons were
incubated with OSI‐906, a competitive inhibitor of IR and IGF‐1R
phosphorylation (Mulvihill et al., 2009). OSI‐906 treatment signifi-
cantly reduced the cholesterol loss‐mediated activation of Akt and
IRS‐1 at Serine 632 (Supporting Information Figure S3A,B), but did
not completely abrogate it because reduced cholesterol also
increases the activity of other tyrosine kinase receptors (RTKs) (Mar-
tin et al., 2008). Nonetheless, the loss of neuronal cholesterol in our
model appears to be sufficiently powerful to induce desensitization
of the insulin pathway.
Next, we performed the converse experiments, adding choles-
terol to old neurons. It has been previously shown that the high
affinity of methyl‐beta‐cyclodextrin (MβCD) for cholesterol can be
used to generate inclusion complexes (MβCD‐Ch) that increase mem-
brane cholesterol levels (Zidovetzki & Levitan, 2007). Thus, hip-
pocampal slices from old mice were incubated with MβCD‐Ch,
following protocols used in a previous study in which we evaluated
the role of membrane cholesterol in the internalization of glutamate
receptors (Martin et al., 2014). The treatment restored cholesterol
content to levels similar to those of adult mice (Figure 2a, see also
ref. Palomer et al., 2016, and Supporting Information Figure S4A).
Consistent with a causal relationship, cholesterol increase in the old
slices reduced PI3K/Akt (Figure 2b), p70S6K Threonine residue 389
(Figure 2c), and GSK3β Serine 9 phosphorylation (Figure 2d), and
rescued insulin‐LTD (Figure 2e). Furthermore, marks of insulin‐desen-
sitized state on IRS‐1 (Serine 632 and Serine 307) were decreased in
the extracts of the cholesterol‐treated slices (Figure 2f,g).
In order to give in vivo relevance to the above results, we inter-
fered with age‐associated cholesterol loss by inhibiting Cyp46A1, the
main catabolic enzyme for cholesterol in the brain (Russell, Halford,
F IGURE 2 Ex vivo cholesterol replenishment in hippocampal slices of old mice restores insulin signaling. (a) Addition of cyclodextrin‐
cholesterol (referred as MβCD‐Ch or Cholesterol) solution to old mice hippocampal slices induces a 20% increase in membrane cholesterol. (b,
c) Cholesterol addition (as in a) reduces hyperactivated Akt and its downstream target p70S6K. (b) Detection of Akt Phospho‐Serine 473; (c)
detection of p70S6K Phospho‐Threonine 389. (d) Cholesterol addition to old hippocampal slices reduces Phospho‐Serine 9 GSK3β inhibitory
residue. (e) Addition of the cholesterol solution to hippocampal slices of old mice rescues the impairment of insulin‐LTD. Graphic showing
insulin‐LTD induction in old mice slices (n = 7) and old mice slices incubated with MβCD‐Ch (n = 9). Black box indicates time of insulin
application. Gray box indicates the time of MβCD‐Ch mix application. Representative analogue traces below were collected at the indicated
time points. (f, g) Cholesterol replenishment decreases insulin resistance marks on IRS‐1 protein. (f) IRS‐1, Phospho‐Serine 632; (g) Phospho‐
Serine 307. The value inside the bars indicates the number of independent experiments. Data are represented as mean ± SEM. t test for (a, b,
d, g), Wilcoxon test for (c, f), one‐way ANOVA with post hoc Bonferroni's test for (e). The asterisks indicate the p values (*p < 0.05;
**p < 0.01)
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Ramirez, Shah, & Kotti, 2009). To that end, the effects of Voricona-
zole, a specific Cyp46A1 inhibitor capable of crossing the blood–
brain barrier, were determined (Shafaati et al., 2010). The oral
administration of Voriconazole for 40 days to 20‐month‐old mice
significantly reduced age‐associated cholesterol loss compared to
untreated old mice (Supporting Information Figure S4A,B), confirming
our previous results (Palomer et al., 2016). Biochemically, hippocam-
pal fractions from the treated mice showed significantly reduced
levels of PI3K/Akt and the downstream effector p70S6K compared
to untreated old mice (Figure 3a,b). Voriconazole treatment also
(a)
Voric.Veh.
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(f)
F IGURE 3 In vivo pharmacological inhibition of cholesterol loss in old mice restores hippocampal insulin sensitivity and insulin‐LTD. (a, b)
Oral administration of the Cyp46A1 inhibitor Voriconazole reduces hippocampal PI3K/Akt and downstream effector p70S6K hyperactivation in
old mice. (a) Western blot of Phospho‐Serine 473 activating residue on Akt. (b) Western blot of p70S6K Phospho‐Threonine 389. (c, d) Oral
treatment with Voriconazole decreases insulin resistance marks in hippocampal samples of old mice. (c) Western blots for IRS‐1 resistance
marks Phospho‐Serine 632; (d) Phospho‐Serine 307. (e) Voriconazole treatment reduces the inhibitory phosphorylation on GSK3β. (f) Graphic
showing insulin‐LTD induction in old mice slices (n = 7) and old mice slices incubated with Voriconazole (n = 8). Hippocampal slices were
incubated with Voriconazole 10 nM for 60 min starting 30 min before insulin stimulus. Black box indicates time of insulin application. Gray box
indicates time of Voriconazole application. Representative analogue traces below were collected at the indicated time points. Bar graphs:
Numbers inside indicate the number of independent experiments. Data are represented as mean ± SEM. t test for (a, b, c, d, e). One‐way
ANOVA with post hoc Bonferroni's test for (F). The asterisks indicate the p values (*p < 0.05)
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resulted in a reduction of insulin resistance marks on IRS‐1
(Figure 3c,d) and the LTD‐inhibitory GSK3β Serine 9 phosphorylation
(Figure 3e). At the electrophysiological level, application of
Voriconazole to hippocampal slices of old mice restored insulin‐LTD
(Figure 3f). All in all, these results are consistent with the possibility
that the decrease in brain cholesterol that occurs with age plays an
important role in the impaired brain insulin function of the old. As
cells of other organs and tissues undergo changes in lipid composi-
tion during aging, and even more so in the case of T2D (Bakan et al.,
2006; Pilon, 2016), insulin resistance of peripheral organs might be
caused, at least in part, by similar mechanism as those in the hip-
pocampus of old mice.
One possible explanation for how a reduced cholesterol environ-
ment could lead to steady receptor activity is by a tighter packaging
of the receptor in liquid‐ordered membrane microdomains (i.e., rafts).
Consistent with this possibility, we observed a significant increase of
IR in the detergent‐insoluble fraction of hippocampal membranes
from old mice compared to adult mice (Supporting Information Fig-
ure S5A). Furthermore, in a preliminary experiment we observed
reduced levels of activity of Akt in the raft fraction of old mice that
had been treated during 40 days with the Cyp46A1 inhibitor Vori-
conazole (Supporting Information Figure S5B), and therefore with
levels of cholesterol similar to younger mice (see Supporting Infor-
mation Figure S4A,B). Together, these last series of results suggest
that aging increases IR clustering and activity in the raft domain of
hippocampal cells. The obvious question that follows is: how is it
possible that there is more receptor activity in the raft fraction in a
membrane with reduced cholesterol?
In principle, the age‐dependent loss of cholesterol, a membrane
rigidity molecule, is inconsistent with the possibility of increased IR
partitioning in ordered domains such as rafts. However, this could
be explained from the increase in plasma membrane sphingomyelin
(SM), also a determinant of plasma membrane rigidity (Colin et al.,
2016), whose levels increase with age and as a consequence of
cholesterol reduction (Colin et al., 2016; Trovò, Van Veldhoven,
Martín, & Dotti, 2011). In support of this possibility, previous
works demonstrated an increase in TrkB receptor clustering in rafts
in the plasma membrane of old neurons in a cholesterol‐reduced
(Martin et al., 2008) and SM‐increased (Trovò, Van Veldhoven,
Martín, & Dotti, 2011) manner. Moreover, also AMPA receptors
are trapped in the membrane raft domain of old neurons due to
reduced cholesterol (Martin et al., 2014). Thus, it appears that
aging disturbs the plasma membrane so that new lipid rafts appear.
This phenomenon can also be seen in cultured neurons of different
ages (14 and 28 days) stained with di‐4‐ANEPPDHQ, a ratiometric
dye that allows quantification of liquid order (Supporting Informa-
tion Figure S5C; Amaro, Reina, Hof, Eggeling, & Sezgin, 2017;
Owen, Rentero, Magenau, Abu‐Siniyeh, & Gaus, 2012). Although
this result is from an “aging‐in‐the‐dish” experiment, it is notewor-
thy that in vitro “aged” hippocampal neurons present numerous
changes that are typical of old hippocampal neurons in vivo, includ-
ing but not limited to the gradual accumulation of senescence
markers and a steady, significant reduction of cholesterol due to
the activation of the Cyp46A1 enzyme (Martin et al., 2008; Sodero
et al., 2011).
The above results led us to speculate that the cholesterol loss
observed in old neurons could facilitate insulin/IGF‐1 activation by
physically packaging the receptor subunit in the ordered domains,
enabling thereby ligand‐independent autophosphorylation. In order
to test this possibility, we transfected cells with full‐length IGF‐1R
constructs bearing fluorescent donor or acceptor tags in the intracel-
lular domain (as in Kavran et al., 2014), followed by fluorescence res-
onance energy transfer (FRET) analysis. As shown in the previous
sections, both IR and IGF‐1R present the same age‐associated activ-
ity increase in a cholesterol‐dependent manner, suggesting that the
FRET results based on IGF‐1R should be comparable to what occurs
with IR and perhaps any other RTK. Previous work has shown that
both receptors require insulin or IGF‐1 binding to their extracellular
domain in order to become active, inducing a conformational change
in the transmembrane domain leading to physical approach and
autophosphorylation of the cytoplasmic tails (Kavran et al., 2014;
Lemmon & Schlessinger, 2010). Previously established acceptor pho-
tobleaching FRET protocols allowed us to assess cytoplasmic tail
proximity in response to different stimuli. Specifically, the donor
intensity upon acceptor photobleaching and transfer of energy
between fluorescent molecules is a measure of their proximity (see
Section 4). To determine whether cholesterol loss could be consid-
ered a general mechanism of ligand‐independent receptor activation,
we performed FRET experiments in two cell types, Hek‐293T and
hippocampal neurons. In Hek‐293T cells, addition of the receptor–li-
gand (IGF‐1) caused the expected increase in FRET efficiency (Sup-
porting Information Figure S6A,B). In order to test whether
cholesterol loss similarly increased FRET, which would support
induction by a similar conformational change, IGF‐1R‐transfected
cells were treated with Choox as in the previous experiments (see
Supporting Information Figure S2). Cholesterol reduction was suffi-
cient per se to significantly increase the receptor's FRET efficiency
(Supporting Information Figure S6C), though at a lower magnitude
than addition of the natural ligand (see quantification in Supporting
Information Figure S6D). This was expected, consistent with the
slow development of insulin resistance parallel to the slow progres-
sion of brain cholesterol changes. Next, we repeated the experiment
in cultured hippocampal neurons, transfected with the same IGF‐1R
carrying EYFP and mCherry tags. Addition of IGF‐1 led to high FRET
efficiency relative to untreated neurons (Figure 4a,b), with similar
results in neurons treated with Choox in the absence of exogenous
ligand (Figure 4c). However, as observed in Hek‐293T cells, the mag-
nitude of the FRET increase was lower in conditions of low choles-
terol compared to the ligand (Figure 4d).
3 | DISCUSSION
Previous studies, in humans and in mice, point in the direction that
some of the cognitive deficits of the old are due, among other
causes, to the decreased levels or activity of insulin and IGF‐1 recep-
tors and to a reduction in the signaling pathway by PI3K/Akt (Deak
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& Sonntag, 2012; Zaia & Piantanelli, 2000). This is quite different
from the increased tonic receptor activity in the hippocampus of old
mice, and increased PI3K/Akt pathway that we show here. The dif-
ferences could be due to (perhaps too simplistic) the type of cellular
or animal model, gender, or age utilized in the different works. On
the other hand, given that in both studies the final result is loss of
insulin signaling, it is not unrealistic to hypothesize that the different
results simply reflect two stages of the same process: that is,
increased basal receptor/PI3K‐Akt activity (as shown here) followed
by reduction in the levels and sensitivity of Insulin/IGF‐1 receptors
(as observed in previous works). More work is needed to determine
whether this hypothesis is correct.
In addition to demonstrating that the insulin and IGF‐1 receptors are
tonically active in the old, we also present evidence that this might be
the consequence of the age‐associated alteration in the neuronal plasma
membrane fluidity due to the reduction in plasma membrane cholesterol
content. Although numerous studies have described changes in brain
cholesterol and their correlation with cognitive deficits during aging, and
in brain disorders such as Alzheimer's disease and T2D (Kadish et al.,
2009; Martín et al., 2014; Palomer et al., 2016; Suzuki, Ferris, Chee,
Maratos‐Flier, & Kahn, 2013; Suzuki et al., 2010), an association
between changes in brain cholesterol and brain insulin resistance has
not been established before. In this work, we present two series of
results that support such a causal link: (a) The loss of insulin function in
old mice can be rescued by either inhibition of cholesterol loss in vivo or
by the addition of cholesterol to hippocampal slices from old mice, and
(b) the removal of cholesterol in young neurons is sufficient to induce
insulin resistance. At a finer mechanistic level, our data are consistent
with the notion that a reduction in the cholesterol content in the plasma
membrane produces molecular rearrangements that favor receptors’
spontaneous (ligand‐independent) activity, for example, by increasing
the proximity of the receptor transmembrane and cytoplasmic domains,
inducing their autophosphorylation and activation (Figure 4e) in a
manner similar to the addition of its natural ligand (Kavran et al., 2014;
Lemmon & Schlessinger, 2010). This is supported, indirectly, by the
higher number of active IR in the detergent‐insoluble domain of hip-
pocampal membranes from old mice (see Supporting Information
Figure S5A). The above conclusion also finds direct support from the
increased fluorescence recovery of the donor–receptor after photo-
bleaching of the acceptor in cells treated with Choox (see Figure 4).
Despite the severe limitations of FRET experiments performed in trans-
fected cells exposed to an acute cholesterol reduction strategy, they
provide a possible explanation for how a lack of cholesterol could lead
to chronic activation of IR/IGF‐1R receptors and pathway desensitiza-
tion. This does not exclude that also other mechanisms such as hyperin-
sulinemia may contribute to such chronic receptor activity.
In addition to increased receptor and post‐receptor (PI3K/Akt)
activity, the loss of cholesterol also produces an increase in activity of
mTORC1. This last result contradicts recent studies that show that
cholesterol increases mTORC1 activity (Castellano et al., 2017). As
before, there are substantial differences in the experimental models
that can easily explain the divergent results (i.e., cell lines vs. hip-
pocampal neurons, in vitro and in vivo, lysosomal mTORC1 vs. cytoso-
lic mTORC1). Irrespective, our demonstration of the existence of a
strong PI3K/Akt activity in the old hippocampus and in conditions of
cholesterol loss (of note: this was also reported in Martín et al., 2014
and in Trovò et al., 2013) makes us feel confident that aging increases
mTORC1 activity in a cholesterol loss/Akt‐dependent manner and that
this can be responsible in part for the negative phosphorylation of IRS‐
1 and desensitization of the insulin signaling pathway. In further agree-
ment, the increase in mTORC1 activity in the old hippocampus and in
cultured hippocampal neurons with reduced cholesterol could explain
the age and cholesterol loss‐dependent increase in P‐p70S6K and in
IRS‐1‐negative phosphorylation.
There may seem to be a contradiction between desensitization of
the insulin pathway and high basal activity levels of the PI3K/Akt path-
way, as the activity of the latter depends on the former. However, it is
worth remembering that PI3K/Akt activity is a common effector of
numerous intracellular pathways, many of which are potentiated during
aging, including interleukin production and activation of other RTKs
(Martin et al., 2008; Xiao, Peng, Gan, Arafat, & Yin, 2016). This “normal”
increase of PI3K/Akt in the cytoplasm of old neurons would explain
why suppression of PI3K activity rescues LTD upon addition of insulin.
Given the fact that the PI3K/Akt cascade is one of the important cell
F IGURE 4 Cholesterol loss favors in neurons the conformational changes required for insulin growth factor 1 receptor's activation. (a, b, c)
FRET experiment. Laser microscopy images of cultured neurons co‐transfected with IGF‐1R‐EYFP (donor fluorophore) and IGF‐1R‐mCherry
(acceptor fluorophore), with the fluorophores replacing the cytosolic tails of the entire receptor sequence. Neurons maintained in
Neurobasal+B27 (without serum) remained un‐stimulated (a), were stimulated with 4 μM IGF‐1 (b), or were treated with 10 IU/ml Choox
before fixation (c). Acceptor signal was bleached, intensity of donor signal was measured, and FRET efficiencies were calculated (see Materials
and Methods). Scale bars represent 10 μm. (d) Cholesterol loss enables in neurons a plasma membrane environment sufficient to induce the
conformational change on IGF‐1R required for receptor activation, thus increasing FRET efficiency. The graphic represents FRET efficiencies
data obtained from 80 images quantified of four independent experiments for each condition. Data are represented as mean ± SEM. One‐way
ANOVA with post hoc Bonferroni's test for (a, b, c). The asterisks indicate the p values (*p < 0.05; ***p < 0.001). (e) Summary of how age
produces insulin resistance in the mouse hippocampus: cholesterol loss, due in part to Cyp46a1 activation (and also to SCAP reduction, and
perhaps others), favors an increase in plasma membrane ordered domains where the IR/IGF‐1R preferentially cluster (membrane yellow
segments). This clustering facilitates the conformational changes required for the receptor's autophosphorylation in a ligand‐independent
manner (phosphor motifs in IR/IGF‐1R). If this type of receptor change occurs over a prolonged period of time and incrementally (as it is the
case with the loss of cholesterol with age), the post‐receptor pathway will also be activated chronically, leading to desensitization (phospho‐
motifs in IRS‐1) and loss of insulin synaptic plasticity function (Akt inhibition on GSK3β and AMPAR inhibited internalization)
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survival pathways (Kim et al., 2002; Miyawaki et al., 2009), neuronal
survival mechanisms seem to be strengthened during aging and this
redefinition of metabolic/organismic priorities occurs to the detriment
of other cellular functions, such as LTD. On the other hand, the high
PI3K/Akt activity observed in the old hippocampus may be the reason
why age does not largely affect the magnitude of LTP (reviewed in
Kumar, 2011), a process highly dependent on PI3K/Akt. Only future
work can bring more light to how the increased activity of the PI3K‐Akt
pathway in the old brain participates in the balance between LTP and
LTD in the hippocampus and between plasticity and survival. Thus, we
believe that besides helping to understand how insulin function
becomes reduced in the brain with age, our work also opens ways to
investigate essential events of aging, such as the relationship between
survival and plasticity.
4 | EXPERIMENTAL PROCEDURES
4.1 | Animal handling
Male adult (7–12 months old) and old (20–24 months old) C57BL/6J
mice were used in this study. All the animals were kept in the Cen-
tro de Biología Molecular Severo Ochoa (CBMSO) animal facility. All
experiments were performed in accordance with European Union
guidelines (2010/63/UE) regarding the use of laboratory animals.
4.2 | Animal treatment
Voriconazole (from Hangzhou Dayangchem Co., China CAS No:
137234‐62‐9) was solubilized using (2‐hydroxypropyl)‐β‐cyclodextrin
(Sigma‐Aldrich, St Louis, MO): 15 g of (2‐hydroxypropyl)‐β‐cyclodex-
trin was dissolved in 100 ml of saline solution (0.9% NaCl) and heated
to 80°C in a water bath with stirring. Then, 1.5 g of Voriconazole was
added to the cyclodextrin solution with stirring at 80°C until complete
dissolution. This stock solution (15 mg Voriconazole/ml cyclodextrin/
saline) was conserved at 4°C protected from light. On the first day of
experimentation, an aliquot of this solution was diluted in drinking
water to a final concentration of 0.68 mg/ml Voriconazole. Consider-
ing that a mouse drinks 3 ml water per day, the dose corresponds to
2.04 mg/day. The average weight of a mouse is 34 g, resulting there-
fore in a dose 60 mg/kg body weight. Water with this concentration of
Voriconazole was used as the hydration source in 20‐month‐old mice
during 45 days. Vehicle 20‐month‐old mice received the same amount
of (2‐hydroxypropyl)‐β‐cyclodextrin than Voriconazole mice during
45 days. Bottles containing the Voriconazole or vehicle water were
changed weekly.
4.3 | Hippocampal slices
Hippocampal slices were obtained from C57BL/6J mice. Hippocampi
were extracted and placed in dissection solution (10 mM D‐glucose,
4 mM KCl, 26 mM NaHCO3, 233.7 mM sucrose, 5 mM MgCl2,
1:1,000 phenol red), oxygen saturated with carbogen (95% O2/5%
CO2), and sliced using an automatic tissue chopper (McIlwain Tissue
Chopper, Standard Table, 220 V; Ted Pella Inc., Redding, CA) to obtain
400 µm hippocampal slices. Then, slices were kept in artificial cere-
brospinal fluid (ACSF: 119 mM NaCl, 2.5 mM KCl, 1 mM NaH2PO4,
11 mM glucose, 1.2 mM MgCl2, 2.5 mM CaCl2, osmolarity adjusted to
290 Osm), oxygen saturated with carbogen for 1 hr. Experiments were
performed in ACSF, oxygen saturated with carbogen.
4.4 | Cell cultures
Hek‐293T cells were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM
glutamine, 100 IU/ml penicillin, and 100 mg/ml streptomycin (com-
plete DMEM). Primary hippocampal neurons were extracted from
Wistar rat embryos at embryonic day 18 (E18), seeded in culture
conditions as previously described (Kaech & Banker, 2006), and kept
in culture for 15 days in vitro (DIV). All cells were incubated at 37°C,
humidity conditions, and 5% CO2.
4.5 | Cell treatments
The following compounds were added to cell medium of hippocam-
pal neurons and Hek‐293T: OSI‐906 (Selleckchem, Houston, TX ref.:
S1091; 1 µM); Cholesterol oxidase (Choox; Calbiochem, San Diego,
CA ref.: 228250; 10 IU/ml); human peptide purified IGF‐1 (Stem Cell
Technologies, Canada #78022; 4 µM). For electrophysiology experi-
ments we used: Insulin (Sigma‐Aldrich, St Louis, MO ref.: I0516;
0.5 µM); Quercetin (Sigma‐Aldrich, St Louis, MO ref.: Q4951;
20 µM); Wortmannin (Tocris, UK ref.: 1232; 0.5 µM); and Voricona-
zole (Hangzhou Dayangchem Co., China; 10 nM). Experiments for
cholesterol addition conducted in hippocampal slices were performed
at 25°C. Methyl‐β‐cyclodextrin‐cholesterol (MβCD‐Ch) solution was
prepared freshly at use concentration in ACSF, containing 30 µM
Cholesterol Water‐soluble (Sigma‐Aldrich, St Louis, MO ref.: C4951)
and 5 µM Cholesterol (Sigma‐Aldrich, St Louis, MO ref.: C3045).
4.6 | Cholesterol quantification
Hippocampal extracts were homogenized in a lysis buffer contain-
ing 25 mM MES, 2 mM EDTA, Phosphatase Inhibitor Cocktail 2
(Sigma‐Aldrich), and Protease Inhibitor Complete (Roche, Switzer-
land). The protein amount was quantified by Pierce® BCA Assay kit
(Thermo Scientific, Waltham, MA) and the cholesterol content mea-
sured per microgram of protein using the Amplex® Red Cholesterol
Assay kit (Invitrogen, Carlsbad, CA).
4.7 | Antibodies
The following antibodies were used for Western blot (WB) and immuno-
precipitation (IP): anti‐α‐Tubulin (WB 1:10,000, Abcam, Cambridge, UK
ref.: ab7291), anti‐β‐Actin (WB 1:20,000; Sigma‐Aldrich ref.: A5441), anti‐
GAPDH (WB 1:20,000; Abcam, ref.: ab8245), anti‐Akt (WB 1:1,000; Cell
Signaling, Danver, MA ref.: #9272), anti–Phospho‐Akt Serine 473 (WB
1:1,000, Cell Signaling ref.: #4060), anti‐GSK3 α/β (WB 1:1,000, Invitrogen,
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Carlsbad, CA ref.: 44–610), anti‐Phospho GSK3 α/β Serine 21/9 (WB
1:1,000; Cell Signaling ref.: #9331), anti‐IGF‐1 Receptor β (WB 1:1,000, IP
1:100; Cell Signaling ref.: #9750), anti‐Phospho IGF‐1 receptor β Tyr1135/
116 (WB 1:1,000; Cell Signaling ref.: #3024), anti‐Insulin receptor β (IP
1:100, Santa Cruz, Dallas, TX ref.: sc‐57342), anti‐Insulin receptor β (WB
1:750, Santa Cruz, Dallas, TX ref.: sc‐711), anti‐Phospho insulin receptor β
Tyr1150/1151 (WB 1:750; Millipore, Burlington, MA ref.: 04‐299), anti‐
IRS‐1 (WB 1:1,000; BD Biosciences, Franklin Lakes, NJ ref.: 611394), anti‐
Phospho IRS‐1 Serine 307 (WB 1:750; Abcam ref.: ab4865), anti‐Phospho
IRS‐1 Serine 632 (WB 1:200; Cell Signaling ref.: #2388), anti‐Phospho IRS‐
1 Serine 1101 (WB 1:1,000; Cell Signaling ref.: #2385), anti‐mTOR (WB
1:1,000; Cell Signaling ref.: #4517), anti‐Phospho mTOR Serine 2448 (WB
1:2,500; Cell Signaling ref.: #5536), anti‐p70S6K (WB 1:1,000; BD Bio-
sciences ref.: 611260), anti‐Phospho p70S6K Threonine 389 (WB 1:750;
Cell Signaling ref.: #9206), anti‐IRS‐2 (WB 1:500, Upstate 06‐506), anti‐
Vinculin (WB 1:1,000; Millipore ref.: AB6039).
4.8 | Insulin receptor sensitivity experiment
Insulin receptor sensitivity was determined in mouse hippocampus by
measuring the capability of the receptor to become active upon ligand
supply. Adult and old male mice were intraperitoneally injected with
27 IU/kg body weight of human purified insulin (Actrapid®, Novo Nor-
disk, Denmark) diluted in saline solution (0.9% NaCl). Injected mice
were kept 1 hr at regular conditions and then sacrificed. Hippocampi
were extracted and processed in RIPA buffer (20 mM Tris‐HCl, pH 7.5,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP‐40, 1% sodium
deoxycholate, 0.1% SDS, Phosphatase Inhibitor Cocktail 2 (Sigma‐
Aldrich), and Protease Inhibitor Complete (Roche, Switzerland). The
protein amount was quantified by Pierce® BCA Assay kit. Samples were
immunoprecipitated using an antibody against insulin receptor, and the
level of receptor phosphorylation was determined by Western blot.
4.9 | Insoluble vs. soluble membrane fraction
isolation:
Extracts from adult and old mice hippocampi were incubated for
40 min at 4°C under rotation in TNE buffer (50 mM Tris–HCl, 150 mM
NaCl, 5 mM EDTA [pH 7.4]) containing 1% Triton X‐100 and a pro-
tease inhibitor cocktail. The suspension was centrifuged at 184000 g
rpm for 1 hr at 4°C. After centrifugation, the detergent‐insoluble mem-
branes (raft) were collected from the pellet, whereas detergent soluble
material (nonraft) was retrieved from the supernatant.
4.10 | Raft fraction isolation
Mice hippocampal extracts were incubated at 4°C for 45 min in 1%
Triton X‐100, 10 mM MES (2‐[N‐morpholino]ethanesulfonic acid) (pH
7.00), 2 mM EDTA, 1 mM DTT, Phosphatase Inhibitor Cocktail 2
(Sigma‐Aldrich), and Protease Inhibitor Complete (Roche). Samples
were brought to 60% sucrose. A discontinuous gradient was overlaid
with 35% and 5% sucrose. After centrifugation at 100,000 g for
18 hr at 4°C, 12 fractions were collected.
4.11 | Fluorescence resonance energy transfer
Insulin‐like growth factor 1 receptor (IGF‐1R) activity was measured
by fluorescence resonance energy transfer (FRET) in hippocampal
neurons in culture or Hek‐293T transfected with IGF‐1R extracellular
and transmembrane regions fused to EYFP (FRET donor) or mCherry
(FRET acceptor). Plasmids were kindly provided by Dr. Patrick. O.
Byrne and Dr. Daniel J. Leahy from Johns Hopkins University School
of Medicine, Baltimore, USA. Neurons were transfected using Lipo-
fectamine 2000 (Thermo Fisher ref.: #11668027). Hek‐293T cells
were transfected using polyethylenimine (PEI) reagent (Polysciences,
Warrington, PA ref.: #23966‐2). Forty‐eight hours later, cells were
treated. Neurons were maintained in Neurobasal+B27 medium with-
out serum for treatments. Hek‐293T cells required 5‐hr starvation in
DMEM without FBS and glutamine previous to treatment. Different
treatments were applied to determine the FRET efficiency: control
situation (cells incubated only with starving medium), positive control
situation (cells incubated with IGF‐1 peptide 4 µM), and study situa-
tion (cells incubated with Choox 10 IU/ml). After treatments, cells
were fixed with 1% PFA for 15 min at room temperature. Finally,
PFA was removed and cells were washed four times in 1× PBS and
mounted onto slides using Mowiol–Dabco (Mowiol, Calbiochem, San
Diego, CA) without antifading. A confocal LSM710 microscope
(Zeiss, Germany) coupled to an inverted AxioObserver Z1 micro-
scope (Zeiss) was used for conducting acceptor photobleaching FRET
experiments. Images were acquired using the following wavelengths:
λexc = 488 nm, λem = 503–532 nm for EYFP; λexc = 561 nm, λem =
600–699 nm for mCherry. Three prebleaching and four postbleach-
ing images were taken in both channels. Photobleaching was per-
formed in delimited regions of interest (ROI) of the cells, in particular
in the plasma membrane of the cells where the IGF‐1R is mainly
located under physiological conditions. Images were taken using a
63× oil objective, and the ROIs used were squares of regular size.
Acceptor signal was bleached up to a 10% of its initial magnitude
applying the highest laser intensity during thirty iterations to the
selected ROI. Zeiss imaging software was used to calculate FRET
efficiency using the following equation:





where Donorpre corresponds EYFP signal before bleaching, and
Donorpost corresponds to final EYFP signal after bleaching. All
images were background‐subtracted.
4.12 | Electrophysiology (insulin‐LTD)
Adult and old mice were tested for synaptic plasticity in the hip-
pocampal CA1 region in vitro. Animals were killed by cervical dislo-
cation, and the hippocampus was rapidly dissected out into ice‐cold
(4°C) ACSF saturated with carbogen. ACSF for electrophysiology
experiments consisted of: 124 mM NaCl, 4.9 mM KCl, 25.6 mM
NaHCO3, 1.20 mM KH2PO4, 2 mM CaCl2, 2 mM MgSO4, 10 mM
glucose, pH 7.4. Transverse slices (400 µm thick) were prepared
from the dorsal area of the right hippocampus with a tissue chopper
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and placed into a submerged‐type chamber, where they were kept
at 32°C and continuously perfused with ACSF at a flow rate of
2.2 ml/min. After 90‐min incubation, one slice was arbitrarily selected
and a tungsten electrode was placed in CA1 stratum radiatum. Field
excitatory postsynaptic potentials (fEPSPs) were recorded by placing
a glass electrode (filled with ACSF, 3–7 MΩ) in the stratum radiatum
opposite the stimulating electrode. The time course of the field EPSP
was measured as the descending slope function for all sets of experi-
ments. After input/output curves had been established, the stimula-
tion strength was adjusted to elicit a fEPSP slope of 35% of the
maximum and kept constant throughout the experiment. During
baseline recording, 3 single stimuli (0.1 ms pulse width; 10‐s interval)
were measured every 5 min and averaged for the 60‐min fEPSP val-
ues. Unless otherwise stated, insulin‐mediated LTD was achieved by
application of 0.5 µM insulin dissolved in ACSF for 30 min com-
mencing at time zero (Huang et al., 2004). Drug or test substances
were applied from 30 min prior to until 30 min after the start of
insulin application. Evoked responses were initially monitored at 1, 4,
7, and 10 min and then continually every 5 min as above.
4.13 | Plasma membrane order experiment
Rat hippocampal neurons were cultured 14 and 28 days in vitro
(DIV) and fixed in 4% PFA. For lipid phase imaging, cells were
stained with di‐4‐ANEPPDHQ (Thermo Fisher) according to the man-
ufacturer's specifications. For imaging, we used a Nikon A1R confo-
cal microscope attached to Ti eclipse outfitted with a Plan Apo VC
60× lens, oil immersion lens, with a NA of 1.4. For imaging, we used
the spectral detector of the system set to 530–590 nm and 590–
650 nm to image the spectral shift of the dye from lipid ordered to
disordered phase. The resulting images were analyzed according to
Owen Rentero Magenau Abu‐Siniyeh and Gaus (2012). To compare
the two groups, the average value of 108 (60 for 14 DIV [12/cover-
slip, 5 experiments] and 48 for 28 DIV [12/coverslip, 4 experiments])
fields of view was reported.
4.14 | Statistical analyses
Statistical analyses were performed with GraphPad Prism 5 (Graph-
Pad Software Inc.). All values are presented as mean ± SEM. Data
normality and variances were tested by the Shapiro–Wilk test.
Mann–Whitney U test, Kruskal–Wallis test, or Friedman test, with
Dunn's adjustment for multiple comparisons, was used for nonpara-
metric data. Student's t test or ANOVA with Bonferroni's adjustment
for multiple comparisons was used for parametric data. Asterisks in
the figures indicate p values as follows: *<0.05; **<0.01; ***<0.001.
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